The V(2) receptor antagonist tolvaptan counteracts proliferation and invasivity in human cancer cells

PURPOSE: Hyponatremia, the most frequent electrolyte alteration in clinical practice, has been associated with a worse prognosis in cancer patients. On the other hand, a better outcome has been related to serum sodium normalization. In vitro studies have shown that low extracellular sodium promotes...

Descripción completa

Detalles Bibliográficos
Autores principales: Marroncini, G., Anceschi, C., Naldi, L., Fibbi, B., Baldanzi, F., Maggi, M., Peri, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360171/
https://www.ncbi.nlm.nih.gov/pubmed/35604542
http://dx.doi.org/10.1007/s40618-022-01807-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360171/
https://www.ncbi.nlm.nih.gov/pubmed/35604542
http://dx.doi.org/10.1007/s40618-022-01807-5

Ejemplares similares